COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 425.7 | 9 | 0313-0650 | 429.31 | 649.95 | 196 | 52.28 | 0.901 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 1485.6 | 9 | 0314-0655 | 504.15 | 656.17 | 268 | 64.18 | 0.818 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 323.0 | 9 | 0315-0652 | 657.70 | 652.90 | 261 | 59.11 | 0.939 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 3677.2 | 9 | 0316-0654 | 70.78 | 654.67 | 174 | 51.11 | 0.837 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 1794.4 | 9 | 0317-0657 | 339.71 | 657.78 | 226 | 56.53 | 0.889 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 301.2 | 9 | 0318-0655 | 383.03 | 655.64 | 149 | 48.87 | 0.784 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 1148.2 | 9 | 0319-0657 | 200.29 | 656.11 | 247 | 59.84 | 0.867 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 1537.4 | 9 | 0320-0658 | 839.59 | 659.58 | 154 | 49.70 | 0.784 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 387.0 | 9 | 0321-0657 | 444.85 | 658.14 | 127 | 47.11 | 0.719 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 2602.1 | 9 | 0322-0661 | 623.12 | 662.42 | 258 | 63.60 | 0.802 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 2151.7 | 9 | 0323-0658 | 568.08 | 658.62 | 172 | 49.70 | 0.875 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 2298.4 | 9 | 0324-0659 | 790.18 | 659.37 | 206 | 54.28 | 0.878 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 272.1 | 9 | 0325-0663 | 35.78 | 663.64 | 240 | 57.94 | 0.898 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 1861.7 | 9 | 0326-0662 | 404.60 | 661.96 | 211 | 57.36 | 0.806 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 342.3 | 9 | 0327-0664 | 162.23 | 664.66 | 252 | 61.94 | 0.825 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 1887.5 | 9 | 0328-0670 | 140.52 | 670.03 | 284 | 64.18 | 0.866 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 1593.7 | 9 | 0329-0672 | 297.72 | 672.30 | 288 | 66.43 | 0.820 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 2365.3 | 9 | 0330-0674 | 875.21 | 673.40 | 244 | 60.53 | 0.837 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 1297.8 | 9 | 0331-0676 | 380.69 | 676.33 | 270 | 67.84 | 0.737 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 410.4 | 9 | 0332-0675 | 91.03 | 674.87 | 253 | 59.60 | 0.895 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 2701.8 | 9 | 0333-0676 | 937.72 | 675.75 | 245 | 59.11 | 0.881 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 2426.5 | 9 | 0334-0674 | 786.59 | 674.75 | 198 | 50.87 | 0.962 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 993.0 | 9 | 0335-0684 | 887.77 | 684.20 | 229 | 60.77 | 0.779 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 1199.6 | 9 | 0336-0686 | 264.85 | 686.00 | 246 | 60.53 | 0.844 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 1896.9 | 9 | 0337-0692 | 837.75 | 693.34 | 241 | 64.43 | 0.730 |